Quarterly Review (Part 6)

Friday August 14, 2026

There are ~386 biotechs that have plausible narratives. That is quite a lot compared to recent years but most also have moved above the channel. So not a lot of BEST setups new setups. Need more IPOs to happen. Anyways… continuing.